Image Source: BioSpectrum India
Bioheaven360 Genotec, an innovative biotech start-up in Delhi, has introduced its pioneering AI-powered genomics diagnosis platform in India. Designed in collaboration with All India Institute of Medical Sciences (AIIMS) New Delhi, the platform has been envisioned with the goal to revolutionize preventive medicine by enabling early disease detection and delivering individualized treatment protocols.
The system takes full advantage of the latest real-time machine learning technology that enables continuous improvement in diagnostic precision with each successive sample of data. It employs deep phenotyping to collect rich phenotypic patient data-gene data, lifestyle, biomarkers, and environmental data. This allows the system to produce highly precise cumulative risk scores, detecting potential susceptibility to disease decades before symptoms.
Initially intended for the early detection of osteoporosis, the platform now addresses a broad spectrum of chronic and complex diseases. Its architecture allows for rapid analysis of higher-dimensional medical data sets, delivering actionable health information and supporting clinicians with AI-based diagnostic tools and adaptive self-learning capabilities.
CEO and Founder of Bioheaven360 Genotec, Dr. Shailendra Vyas spoke about the company's mission: "Our platform is going to revolutionize preventive healthcare by giving people personalized recommendations for reducing risk and improving health outcomes. We empower people to make proactive, informed decisions towards a healthier life."
Through this launch, Bioheaven360 Genotec stands at the frontier of precision medicine in India through the use of genomics, AI, and preventive medicine to empower the patients as well as the doctors.
Source: BioSpectrum IndiaBioheaven360 Genotec, an innovative biotech start-up in Delhi, has introduced its pioneering AI-powered genomics diagnosis platform in India. Designed in collaboration with All India Institute of Medical Sciences (AIIMS) New Delhi, the platform has been envisioned with the goal to revolutionize preventive medicine by enabling early disease detection and delivering individualized treatment protocols.
The system takes full advantage of the latest real-time machine learning technology that enables continuous improvement in diagnostic precision with each successive sample of data. It employs deep phenotyping to collect rich phenotypic patient data-gene data, lifestyle, biomarkers, and environmental data. This allows the system to produce highly precise cumulative risk scores, detecting potential susceptibility to disease decades before symptoms.
Initially intended for the early detection of osteoporosis, the platform now addresses a broad spectrum of chronic and complex diseases. Its architecture allows for rapid analysis of higher-dimensional medical data sets, delivering actionable health information and supporting clinicians with AI-based diagnostic tools and adaptive self-learning capabilities.
CEO and Founder of Bioheaven360 Genotec, Dr. Shailendra Vyas spoke about the company's mission: "Our platform is going to revolutionize preventive healthcare by giving people personalized recommendations for reducing risk and improving health outcomes. We empower people to make proactive, informed decisions towards a healthier life."
Through this launch, Bioheaven360 Genotec stands at the frontier of precision medicine in India through the use of genomics, AI, and preventive medicine to empower the patients as well as the doctors.
Source: BioSpectrum India
Advertisement
Advertisement
